Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B.A. Hadaschik
Pcn37 - Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide
Clinical Medicine Insights: Oncology
Oncology
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
Apalutamide for the Treatment of Non‐metastatic Prostate Cancer
Prescriber
Pharmacology
The Addition of Apalutamide to ADT in the Treatment of Metastatic Castration-Sensitive Prostate Cancer: Safety and Efficacy
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
Pcn153 - Cost-Effectiveness Analysis of Apalutamide for Treatment in Non- Metastasis Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Evidence for the Efficacy of Enzalutamide in Postchemotherapy Metastatic Castrate-Resistant Prostate Cancer
Therapeutic Advances in Urology
Urology
Budget Impact Analysis of Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer From a u.s. Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pharmacoeconomic Evaluation of Enzalutamide, Abiraterone and Cabazitaxel for the Treatment of Post-Chemotherapy Patients With Metastatic Castration-Resistant Prostate Cancer
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
